BALTIMORE--(BUSINESS WIRE)--Infinity Bio, Inc. announces its new antibody profiling platform, leveraging Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology. This platform offers ...
“Brian brings a proven track record of translating cutting-edge technologies into widely adopted platforms,” said Malek Fahem, Chief Scientist at Illumina Ventures. “His leadership will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results